Mulmit

Adagene Inc.Adagene Inc.

ADAG Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-317,670,902-21,438,295-17,609,413-0.3
2024-12-31103,204-35,951,543-33,424,111-0.59
2023-12-3118,111,491-23,719,866-18,946,370-0.35
2022-12-319,292,724-83,920,683-79,971,847-0.31
2021-12-3110,175,258-72,364,089-73,177,935-1.46

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-14DO CUONG V2,000
2026-08-13Zhu Li20,000
2026-08-13Cheung Andy Yiu Leung20,000
2026-08-13DO CUONG V20,000
2026-08-13Grawunder Ulf20,000
2026-08-05Luo PeterChief Executive Officer279
2026-08-04Luo PeterChief Executive Officer22,966
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.